Valeant names Anne Whitaker VP, group chairman: 4 things to know

Valeant named Anne Whitaker executive vice president and group chairman, according to a Medical Marketing & Media report.

Here are four things to know:

1. Ms. Whitaker is the president and CEO of Synta Pharmaceuticals.

2. She has extensive experience in sales, marketing and commercial management of gastrointestinal and oncology products.

3. Before joining Synta, she was president of North American Pharmaceuticals for Sanofi, where she headed Sanofi's collaboration with AgaMatrix.

4. Synta's current COO and Vice president Chen Schor will take over as president and CEO after Ms. Whitaker's departure.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

ASC_GI_300x250

Featured Webinars

Featured Whitepapers

Featured Podcast